Centre for Clinical Pharmacology, Division of Medicine, University College London, London, UK.
J Pathol. 2013 Sep;231(1):8-20. doi: 10.1002/path.4232.
Patients with critical illness, and in particular sepsis, are now recognized to undergo unifying, pathogenic disturbances of immune function. Whilst scientific and therapeutic focus has traditionally been on understanding and modulating the initial pro-inflammatory limb, recent years have witnessed a refocusing on the development and importance of immunosuppressive 'anti-inflammatory' pathways. Several mechanisms are known to drive this phenomenon; however, no overriding conceptual framework justifies them. In this article we review the contribution of pro-resolution pathways to this phenotype, describing the observed immune alterations in terms of either a failure of resolution of inflammation or the persistence of pro-resolution processes causing inappropriate 'injurious resolution'-a novel hypothesis. The dysregulation of key processes in critical illness, including apoptosis of infiltrating neutrophils and their efferocytosis by macrophages, are discussed, along with the emerging role of specialized cell subtypes Gr1(+) CD11b(+) myeloid-derived suppressor cells and CD4(+) CD25(+) FoxP3(+) T-regulatory cells.
患有危重病的患者,特别是脓毒症患者,现在被认为会经历免疫功能的统一、致病性紊乱。虽然科学和治疗的重点传统上一直是理解和调节最初的促炎分支,但近年来人们重新关注了免疫抑制的“抗炎”途径的发展和重要性。有几种已知的机制可以驱动这种现象;然而,没有一个占主导地位的概念框架可以证明它们是合理的。在本文中,我们回顾了促解决途径对这种表型的贡献,根据炎症消退的失败或导致不适当的“损伤性消退”的促解决过程的持续来描述观察到的免疫改变,这是一个新的假设。讨论了危重病中关键过程的失调,包括浸润中性粒细胞的凋亡及其被巨噬细胞吞噬,以及专门的细胞亚型 Gr1(+) CD11b(+)髓源性抑制细胞和 CD4(+) CD25(+) FoxP3(+) T 调节细胞的新兴作用。
Immunol Rev. 2016-9
Front Immunol. 2020
Front Immunol. 2021
Infect Drug Resist. 2025-8-25
Vaccines (Basel). 2023-1-19
Clin Immunol. 2022-5
Nan Fang Yi Ke Da Xue Xue Bao. 2021-5-20